In B-ALL cells, the activated PI3K/mTOR signaling pathway makes pS6+ cells rely on glucose for uridine synthesis. As the rate-limiting enzyme in de novo uridine synthesis, DHODH inhibition blocks uridine synthesis and sensitizes B-ALL to chemotherapy. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.